Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160990505> ?p ?o ?g. }
- W2160990505 endingPage "3629" @default.
- W2160990505 startingPage "3619" @default.
- W2160990505 abstract "ABSTRACT Human immunodeficiency virus (HIV) transmission typically results from infection by a single transmitted/founder (T/F) variant. Are T/F variants chosen uniformly at random from the donor pool, or are they selected based on advantageous traits facilitating transmission? Finding evidence for selection during transmission is of particular interest, because it would indicate that phenotypic and/or genetic properties of the viruses might be harnessed as potential vaccine targets or immunotherapies. Here, we systematically evaluated the differences between the Env proteins of simian immunodeficiency virus/simian HIV (SIV/SHIV) stock and T/F variants in search of “signature” sites of transmission. We also surveyed residue preferences in HIV at the SIV/SHIV signature sites. Four sites of gp120 showed significant selection, and an additional two sites showed a similar trend. Therefore, the six sites clearly differentiate T/F viruses from the majority of circulating variants in the stocks. The selection of SIV/SHIV could be inferred reasonably across both vaccinated and unvaccinated subjects, with infections resulting from vaginal, rectal, and intravenous routes of transmission and regardless of viral dosage. The evidence for selection in SIV and SHIV T/F variants is strong and plentiful, and in HIV the evidence is suggestive though commensurate with the availability of suitable data for analysis. Two of the signature residues are completely conserved across the SIV, SHIV, and HIV variants we examined. Five of the signature residues map to the C1 region of gp120 and one to the signal peptide. Our data raise the possibility that C1, while governing the association between gp120 and gp41, modulates transmission efficiency, replicative fitness, and/or host cell tropism at the level of virus-cell attachment and entry. IMPORTANCE The present study finds significant evidence of selection on gp120 molecules of SIV/SHIV T/F viruses. The data provide ancillary evidence suggesting the same sites are under selection in HIV. Our findings suggest that the signature residues are involved in increasing the transmissibility of infecting viruses; therefore, they are potential targets for developing a vaccine or other protective measures. A recent study identified the same T/F signature motif but interpreted it as an effect of neutralization resistance. Here, we show that the T/F motif has broader functional significance beyond neutralization sensitivity, because it is present in nonimmune subjects. Also, a vaccine regimen popular in animal trials might have increased the transmission of variants with otherwise low transmission fitness. Our observations might explain why many animal vaccine trials have not faithfully predicted outcomes in human vaccine trials and suggest that current practices in vaccine design need to be reexamined accordingly." @default.
- W2160990505 created "2016-06-24" @default.
- W2160990505 creator A5024529262 @default.
- W2160990505 creator A5030545878 @default.
- W2160990505 creator A5039386346 @default.
- W2160990505 creator A5040770925 @default.
- W2160990505 date "2015-04-01" @default.
- W2160990505 modified "2023-09-26" @default.
- W2160990505 title "Conserved Molecular Signatures in gp120 Are Associated with the Genetic Bottleneck during Simian Immunodeficiency Virus (SIV), SIV-Human Immunodeficiency Virus (SHIV), and HIV Type 1 (HIV-1) Transmission" @default.
- W2160990505 cites W1895363198 @default.
- W2160990505 cites W1963704583 @default.
- W2160990505 cites W1998893444 @default.
- W2160990505 cites W1999483871 @default.
- W2160990505 cites W2000885937 @default.
- W2160990505 cites W2002574877 @default.
- W2160990505 cites W2007089157 @default.
- W2160990505 cites W2016582810 @default.
- W2160990505 cites W2019405644 @default.
- W2160990505 cites W2020355483 @default.
- W2160990505 cites W2021039830 @default.
- W2160990505 cites W2025005245 @default.
- W2160990505 cites W2028101850 @default.
- W2160990505 cites W2043597268 @default.
- W2160990505 cites W2054351966 @default.
- W2160990505 cites W2060119188 @default.
- W2160990505 cites W2068718867 @default.
- W2160990505 cites W2072620819 @default.
- W2160990505 cites W2074179519 @default.
- W2160990505 cites W2091262391 @default.
- W2160990505 cites W2095497026 @default.
- W2160990505 cites W2095632120 @default.
- W2160990505 cites W2099311529 @default.
- W2160990505 cites W2110233649 @default.
- W2160990505 cites W2114288367 @default.
- W2160990505 cites W2121914783 @default.
- W2160990505 cites W2124039449 @default.
- W2160990505 cites W2126515754 @default.
- W2160990505 cites W2126843316 @default.
- W2160990505 cites W2133750999 @default.
- W2160990505 cites W2143421242 @default.
- W2160990505 cites W2144266766 @default.
- W2160990505 cites W2144539981 @default.
- W2160990505 cites W2146672876 @default.
- W2160990505 cites W2147046090 @default.
- W2160990505 cites W2147169218 @default.
- W2160990505 cites W2153670011 @default.
- W2160990505 cites W2156178056 @default.
- W2160990505 cites W2160378127 @default.
- W2160990505 cites W4211179183 @default.
- W2160990505 cites W4290305201 @default.
- W2160990505 doi "https://doi.org/10.1128/jvi.03235-14" @default.
- W2160990505 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4403421" @default.
- W2160990505 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25589663" @default.
- W2160990505 hasPublicationYear "2015" @default.
- W2160990505 type Work @default.
- W2160990505 sameAs 2160990505 @default.
- W2160990505 citedByCount "23" @default.
- W2160990505 countsByYear W21609905052015 @default.
- W2160990505 countsByYear W21609905052016 @default.
- W2160990505 countsByYear W21609905052017 @default.
- W2160990505 countsByYear W21609905052018 @default.
- W2160990505 countsByYear W21609905052019 @default.
- W2160990505 countsByYear W21609905052020 @default.
- W2160990505 countsByYear W21609905052021 @default.
- W2160990505 countsByYear W21609905052022 @default.
- W2160990505 countsByYear W21609905052023 @default.
- W2160990505 crossrefType "journal-article" @default.
- W2160990505 hasAuthorship W2160990505A5024529262 @default.
- W2160990505 hasAuthorship W2160990505A5030545878 @default.
- W2160990505 hasAuthorship W2160990505A5039386346 @default.
- W2160990505 hasAuthorship W2160990505A5040770925 @default.
- W2160990505 hasBestOaLocation W21609905051 @default.
- W2160990505 hasConcept C104317684 @default.
- W2160990505 hasConcept C119599485 @default.
- W2160990505 hasConcept C127413603 @default.
- W2160990505 hasConcept C141231307 @default.
- W2160990505 hasConcept C159047783 @default.
- W2160990505 hasConcept C2522874641 @default.
- W2160990505 hasConcept C2776488936 @default.
- W2160990505 hasConcept C2777995582 @default.
- W2160990505 hasConcept C2779690655 @default.
- W2160990505 hasConcept C2780727368 @default.
- W2160990505 hasConcept C54355233 @default.
- W2160990505 hasConcept C7386963 @default.
- W2160990505 hasConcept C761482 @default.
- W2160990505 hasConcept C86803240 @default.
- W2160990505 hasConceptScore W2160990505C104317684 @default.
- W2160990505 hasConceptScore W2160990505C119599485 @default.
- W2160990505 hasConceptScore W2160990505C127413603 @default.
- W2160990505 hasConceptScore W2160990505C141231307 @default.
- W2160990505 hasConceptScore W2160990505C159047783 @default.
- W2160990505 hasConceptScore W2160990505C2522874641 @default.
- W2160990505 hasConceptScore W2160990505C2776488936 @default.
- W2160990505 hasConceptScore W2160990505C2777995582 @default.
- W2160990505 hasConceptScore W2160990505C2779690655 @default.
- W2160990505 hasConceptScore W2160990505C2780727368 @default.
- W2160990505 hasConceptScore W2160990505C54355233 @default.
- W2160990505 hasConceptScore W2160990505C7386963 @default.